List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 153 studies with search of: Ethinyl Estradiol
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females
Condition: Contraception
Intervention: Drug: Norgestimate/ethinyl estradiol; Drospirenone/ethinyl estradiol
2 Completed Comparison of Efficacy and Safety of Norgestimate-Ethinyl Estradiol and Cyproterone Acetate-Ethinyl Estradiol in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: Norgestimate-ethinyl estradiol; Cyproterone acetate-ethinyl estradiol
3 Completed Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea
Condition: Dysmenorrhea
Interventions: Drug: Ethinylestradiol / Drospirenon ( SH TO4740B;   Drug: Ethinylestradiol / Drospirenon ( SH TO4740F);   Drug: Ethinylestradiol / Drospirenon ( SH TOO186DF);   Drug: Ethinylestradiol / Drospirenon
4 Completed An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen
Condition: Metrorrhagia
Intervention: Drug: norelgestromin/ethinyl estradiol
5 Completed Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation
Condition: Ovulation
Interventions: Drug: Levonorgestrel;   Drug: Ethinyl Estradiol
6 Completed Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral Contraceptive
Condition: Contraception
Intervention: Drug: Nestorone/ethinyl estradiol contraceptive vaginal ring; levonorgestrel/ethinyl estradiol oral contraceptive
7 Recruiting Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)
Conditions: Contraception;   Ovulation Inhibition
Intervention: Drug: Ethinylestradiol/Gestodene (BAY86-5016)
8 Completed A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA® (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST® (an Oral Contraceptive)
Conditions: Contraception;   Female Contraception
Intervention: Drug: EVRA® transdermal contraceptive patch containing 6 mg of norelgestromin and 0.60 mg of ethinyl estradiol (versus CILEST® tablets).
9 Completed Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females
Condition: HIV Infections
Interventions: Drug: Ortho Tri-Cyclen (ethinyl estradiol + norgestimate);   Drug: Ortho Tri-Cyclen LO (ethinyl estradiol + norgestimate) + Atazanavir/Ritonavir for 14 days then Ortho Tri-Cyclen for 7 days
10 Completed An Open-Label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol
Condition: Contraception
Intervention: Drug: norelgestromine and ethinyl estradiol
11 Completed Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS
Condition: Premenstrual Syndrome
Intervention: Drug: Levonorgestrel/Ethinyl Estradiol
12 Completed Evaluation of Women's Experience With EVRA® (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.
Conditions: Contraception;   Female Contraception
Intervention: Drug: norelgestromin + ethinyl estradiol
13 Completed Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
Conditions: Premenstrual Syndrome;   Menstruation Disturbances
Intervention: Drug: Levonorgestrel/Ethinyl Estradiol
14 Completed Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder
Conditions: Menstruation Disturbances;   Premenstrual Syndrome
Intervention: Drug: levonorgestrel/ethinyl estradiol
15 Withdrawn Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women
Condition: Contraception
Intervention: Drug: Levonorgestrel/Ethinyl Estradiol
16 Completed An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
Condition: Metrorrhagia
Intervention: Drug: Norgestimate/Ethinyl Estradiol tablet
17 Completed TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
Conditions: HIV;   AIDS;   Oral Contraceptive
Intervention: Drug: TMC278
18 Completed A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women.
Conditions: Drug Interactions;   Healthy;   Pharmacokinetics
Intervention: Drug: Norgestimate; Ethinyl Estradiol; Folic acid
19 Completed Bioequivalence Study of the Oral Contaceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
Conditions: Therapeutic Equivalency;   Contraceptives, Oral;   Pharmacokinetics
Intervention: Drug: Norgestimate; Ethinyl Estradiol; Folic acid.
20 Active, not recruiting Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Using Oral Contraceptives
Conditions: Female Contraception;   Contraception
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options